Bio

Rob was most recently a Managing Director at Altaris Capital Partners, a leading healthcare-focused private equity firm based in New York, where he led the firm's investments in the pharma and life sciences sectors. He has broad experience investing across the healthcare and technology industries, in companies based in Europe, the US and in Asia. Prior to Altaris, he worked at HgCapital in London, Ares Life Sciences in Geneva, and Sofinnova Partners in Paris. Before investing Rob was a neuroscientist and has published research into neurodegenerative diseases. He has an MBiochem in Biochemistry and a DPhil in Neurology from the University of Oxford.